1-4 of 4
Monika Podhorecka, MD, PhD
Close
Sort by
Journal Articles

Clinical Efficacy and Safety of Combined Thalidomide and Fludarabine Therapy in B-Cell Chronic Lymphocytic Leukemia Patients.

Anna Dmoszynska, Krzysztof Giannopoulos, MD, PhD, Malgorzata Kowal, MD, PhD, Monika Podhorecka, MD, PhD, Paulina Wlasiuk, MSc, Agnieszka Bojarska-Junak, PhD, Wioletta Trzesniewska, MD, Jacek Rolinski
Journal: Blood
Blood (2006) 108 (11): 4975.
https://doi.org/10.1182/blood.V108.11.4975.4975
Published: 2006
Journal Articles

High Frequency of T Regulatory Cells in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Is Decreased by Thalidomide and Fludarabine Treatment.

Krzysztof Giannopoulos, MD, PhD, Michael Schmitt, MD PhD, Paulina Wlasiuk, MS C, Malgorzata Kowal, MD PhD, Monika Podhorecka, MD PhD, Jacek Rolinski, Anna Dmoszynska
Journal: Blood
Blood (2006) 108 (11): 2108.
https://doi.org/10.1182/blood.V108.11.2108.2108
Published: 2006
Journal Articles

Lovastatin and Thalidomide Have an Synergic Effect on the Rate of Multiple Myeloma Cell Apoptosis in Short Term Cell Cultures.

Monika Podhorecka, MD, PhD, Piotr Klimek, MSc, Norbert Grzasko, MD, Anna Dmoszynska, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5121.
https://doi.org/10.1182/blood.V106.11.5121.5121
Published: 2005
Journal Articles

ZAP-70 Versus CD38 Expression as the Prognostic Factors in B-Cell Chronic Lymphocytic Leukemia.

Iwona Hus, MD, PhD, Agnieszka Bojarska-Junak, MD, PhD, Monika Podhorecka, MD, PhD, Ewa Wasik-Szczepanek, MD, PhD, Malgorzata Sieklucka, MD, Katarzyna Skorzynska, MD, Jacek Rolinski, MD, PhD, Anna Dmoszynska, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4780.
https://doi.org/10.1182/blood.V104.11.4780.4780
Published: 2004